Save your place

Sign in to WhoBought

Please try again later.

Cyclacel Pharmaceuticals, Inc. (CYCC) institutional ownership

Market cap$11M SectorHealthcare
Funds holding · Q1 2026
10
reported CYCC position changes
Top owners · Q2 2026
No disclosed owners are available.
Institutional activity · Q1 2026
Activity unavailable N/A
7 buyers · 3 sellers

Cyclacel Pharmaceuticals, Inc. (CYCC) price and institutional activity

Dates

Q1 2026

$0 sold by 3 investors
Two Sigma Securities, LLCDrw Securities, LLC +1 more
Bought Sold Totals per quarter; hover a bar for the names.

Cyclacel Pharmaceuticals, Inc. (CYCC) institutional activity · 10

Investor Type Est. change Change Δ Own Date
Two Sigma Securities, LLC · Exited
Change −28K Δ Own −100.0% Date Q1 2026
Two Sigma Securities, LLC Exited· Q1 2026 −28K −100.0% Q1 2026
Drw Securities, LLC · Exited
Change −25K Δ Own −100.0% Date Q1 2026
Drw Securities, LLC Exited· Q1 2026 −25K −100.0% Q1 2026
Renaissance Technologies LLC Added· Q1 2026 +24K +104.0% Q1 2026
Citadel Advisors LLC New· Q1 2026 +22K Q1 2026
Xtx Topco Ltd · New
Change +22K Date Q1 2026
Xtx Topco Ltd New· Q1 2026 +22K Q1 2026
Geode · New
Change +22K Date Q1 2026
Geode New· Q1 2026 +22K Q1 2026
UBS Group AG · Added
Change +2K Date Q1 2026
UBS Group AG Added· Q1 2026 +2K Q1 2026
Tower Research Capital LLC (trc) · Added
Change +1K Date Q1 2026
Tower Research Capital LLC (trc) Added· Q1 2026 +1K Q1 2026
Sbi Securities Co., Ltd. · Added
Change +498 Date Q1 2026
Sbi Securities Co., Ltd. Added· Q1 2026 +498 Q1 2026
Bank of America Corp · Exited
Change −2 Δ Own −100.0% Date Q1 2026
Bank of America Corp Exited· Q1 2026 −2 −100.0% Q1 2026
Data through Q1 2026 · filed May 15, 2026
10 of 10

Famous investor activity in Cyclacel Pharmaceuticals, Inc. (CYCC)

Cyclacel Pharmaceuticals, Inc. (CYCC) insider trading

Company insiders, action and economics first; trade and filed dates last.
Dates
Insider Title Type Price Qty Value Owned ΔOwn Trade date Filed date
Kua Khai Loon · 10% Owner Sell −$134K
Price $7.01 Qty −19K Owned 385K Trade date Sep 5, 2025 Filed date Sep 10, 2025
Kua Khai Loon 10% Owner Sell $7.01 −19K −$134K 385K Sep 5, 2025 Sep 10, 2025
Yap Kim Choy · 10% Owner 2 operations 0
Owned 32K Trade date Sep 4, 2025 Filed date Sep 4, 2025
Yap Kim Choy 10% Owner 2 operations 0 32K Sep 4, 2025 Sep 4, 2025
Kua Khai Loon · 10% Owner 2 operations 0
Owned 32K Trade date Sep 4, 2025 Filed date Sep 4, 2025
Kua Khai Loon 10% Owner 2 operations 0 32K Sep 4, 2025 Sep 4, 2025
Ong Yee Lung · 10% Owner 2 operations 0
Owned 32K Trade date Sep 4, 2025 Filed date Sep 4, 2025
Ong Yee Lung 10% Owner 2 operations 0 32K Sep 4, 2025 Sep 4, 2025
Lazar David E. · 10% Owner Sell −$83K
Price $12.36 Qty −7K Owned 156K Trade date Jul 30, 2025 Filed date Aug 4, 2025
Lazar David E. 10% Owner Sell $12.36 −7K −$83K 156K Jul 30, 2025 Aug 4, 2025
Natan David · Director Grant (A) 700K
Owned 700K Trade date Feb 26, 2025 Filed date Feb 28, 2025
Natan David Director Grant (A) 700K 700K Feb 26, 2025 Feb 28, 2025
Lazar David E. · Officer, 10% Owner Sell −$5.8M
Price $0.03 Qty −194.6M Owned 0 Trade date Feb 26, 2025 Filed date Feb 28, 2025
Lazar David E. Officer, 10% Owner Sell $0.03 −194.6M −$5.8M 0 Feb 26, 2025 Feb 28, 2025
Lazar David E. · Officer, 10% Owner 4 operations 191.9M
Owned 355K Trade date Feb 26, 2025 Filed date Feb 28, 2025
Lazar David E. Officer, 10% Owner 4 operations 191.9M 355K Feb 26, 2025 Feb 28, 2025
Ben-Tzvi Avraham · Director Grant (A) 700K
Owned 700K Trade date Feb 26, 2025 Filed date Feb 28, 2025
Ben-Tzvi Avraham Director Grant (A) 700K 700K Feb 26, 2025 Feb 28, 2025
Lazar David E. · Officer Grant (A) 2.1M
Owned 2.1M Trade date Feb 6, 2025 Filed date Feb 10, 2025
Lazar David E. Officer Grant (A) 2.1M 2.1M Feb 6, 2025 Feb 10, 2025
Natan David · Director Grant (A) 100K
Owned 100K Trade date Jan 2, 2025 Filed date Jan 7, 2025
Natan David Director Grant (A) 100K 100K Jan 2, 2025 Jan 7, 2025
Schwartz Brian · Director, Officer 2 operations 25K
Owned 12K Trade date Jan 29, 2024 Filed date Jan 31, 2024
Schwartz Brian Director, Officer 2 operations 25K 12K Jan 29, 2024 Jan 31, 2024
McBarron Paul · Director, Officer Buy +$6K
Price $3.32 Qty +2K Owned 33K Trade date Dec 21, 2023 Filed date Dec 26, 2023
McBarron Paul Director, Officer Buy $3.32 +2K +$6K 33K Dec 21, 2023 Dec 26, 2023
McBarron Paul · Director, Officer Other Form 4 event (P, derivative) 2K
Owned 2K Trade date Dec 21, 2023 Filed date Dec 26, 2023
McBarron Paul Director, Officer Other Form 4 event (P, derivative) 2K 2K Dec 21, 2023 Dec 26, 2023
Rombotis Spiro George · Director, Officer Buy +$20K
Price $3.32 Qty +6K Owned 69K Trade date Dec 21, 2023 Filed date Dec 26, 2023
Rombotis Spiro George Director, Officer Buy $3.32 +6K +$20K 69K Dec 21, 2023 Dec 26, 2023
15 of 16
15 of 16 Sign in to continue to older insider transactions.

Cyclacel Pharmaceuticals, Inc. (CYCC) activist and large shareholders

Dates
No Schedule 13D or 13G filing is available for CYCC in this range.

Cyclacel Pharmaceuticals, Inc. (CYCC) ownership FAQ

Who owns CYCC?

10 reporting institutions disclosed CYCC position changes in the Q1 2026 snapshot.

How is institutional activity calculated?

For each manager, WhoBought compares accepted consecutive 13F share counts. Share change is current shares minus prior shares. Estimated dollar change is that signed share change multiplied by the split-adjusted quarter-mean close. The activity table on this page uses Q1 2026.

What are activist and large shareholder filings?

An investor crossing 5% of a share class generally files Schedule 13D for activist intent or Schedule 13G for a passive position. The technical form names appear here rather than in the activity rows.

Where does this data come from?

Ownership and institutional activity come from SEC Form 13F filings. Insider activity comes from SEC Form 4, and large-shareholder activity from SEC Schedules 13D and 13G. FMP supplies price data only. Company logos use the local verified Parqet cache with one shared fallback.

Why are ownership reports delayed?

Form 13F is a quarterly disclosure and is normally filed after the quarter ends. Every ownership and activity value therefore names its represented period; it is not presented as a live position.

How are missing table values shown?

A muted dash marks a missing table value. It means the filing omitted the value, comparable data is unavailable, or no prior position exists for comparison.